March 30, 2022 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health announced plans to build a 574,670 square foot medical distribution center in the Columbus, Ohio area. The new building will integrate automation and technology to work alongside Cardinal Health employees; improve safety, service and quality; deliver operational efficiencies; and better support fluctuations in volume and labor to provide customers with
March 17, 2022 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health has launched the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate (CHG). The drape features Avery Dennison’s patented BeneHold CHG adhesive technology, which helps reduce the risk of surgical site contamination with organisms typically associated with surgical site infections (SSIs). The incise film is strong, conformable and breathable and
February 21, 2022 by Chain Drug Review
Cardinal Health, Emily Berlin
Leading Headlines, Pharmacy
DUBLIN, Ohio — Throughout the COVID-19 pandemic, experts in diagnostic testing have continued to develop new tests for respiratory pathogens, new testing methodologies and new approaches. Testing can play an important role in surveillance, identifying those with COVID who are asymptomatic and need to isolate. And, some tests, called serologic tests, show prior infection or
February 10, 2022 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health has been recognized by Forbes as one of America’s Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more, across dozens of industries. Forbes identified America’s Best Employers through an independent survey taken by approximately 60,000 American employees working for U.S. companies that employ
February 10, 2022 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health has been certified a 2022 Top Employer in Mexico, recognized for excellence in human resources practices. Cardinal Health employs about 5,500 people in the company’s five manufacturing facilities in Mexico. The certification was awarded by the Top Employers Institute, which recognizes organizations that focus on putting people first through exceptional
February 7, 2022 by Chain Drug Review
2022 Biosimilar Report: The U.S. Journey and Path Forward, Biosimilar drugs, Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health has published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer coverage with survey data from health care providers, and views from leading physicians and experts on biosimilars. The report delivers robust data and insights
January 14, 2022 by Chain Drug Review
Cardinal Health, supply chain
Leading Headlines, Pharmacy
DUBLIN, Ohio — The incredible daily pressures facing the health care industry – from surges in patient volume to near-constant pandemic-related supply chain disruption to health care workers with serious burnout – need innovative solutions that harness the power of technology. Innovations can give visibility into the supply chain, create efficiencies and eliminate some manual tasks,
December 3, 2021 by Chain Drug Review
Cardinal Health, drug supply chain
Leading Headlines, Pharmacy
DUBLIN, Ohio — Since the onset of COVID-19 in early 2020, nearly every aspect of the global healthcare supply chain has been disrupted, creating shortages or potential shortages of everything from personal protective equipment (PPE) to medical devices to prescription medications. In addition to worldwide shipping delays, the supply chain was further challenged by a
November 18, 2021 by Chain Drug Review
Cardinal Health, WaveMark
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health announced its business, WaveMark Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. “WaveMark is among the first in the industry to optimize clinical lab processes through cutting-edge automation,” said Shawn McBride, vice president and general manager, WaveMark. “Timing matters in the lab: the
November 16, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — According to a story in today’s Wall Street Journal, Cardinal Health plans to test the use of drones with Zipline International Inc. to deliver medications, inhalers and other items to U.S. pharmacies – with the goal of saving time and transport costs. Pending Federal Aviation Administration approvals, the pilot program will begin
November 9, 2021 by Chain Drug Review
Cardinal Health
Business, Leading Headlines
DUBLIN, Ohio — Cardinal Health reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings were $415 million and GAAP diluted earnings per share (EPS) were $0.94. Prior year first quarter GAAP results included an operating loss of $624 million due to a $1.0 billion pretax
October 11, 2021 by Chain Drug Review
Cardinal Health, NCPA CEO B. Douglas Hoey, The 2021 NCPA Digest
Leading Headlines, Pharmacy
CHARLOTTE, N.C. – The 2021 NCPA Digest, sponsored by Cardinal Health, was released Monday as part of the National Community Pharmacists Association’s Annual Convention. The NCPA Digest, which provides an annual overview of independent community pharmacy, found that the industry in 2020 represented 34% of all retail pharmacies in the United States and a $67.1 billion marketplace. “In
October 6, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy
DUBLIN, Ohio — While demand for rheumatology care continues to grow, rheumatologists are feeling pressured by reimbursement changes, administrative duties and workforce shortages. These findings were released today in the latest edition of Rheumatology Insights, a research-based report published by Cardinal Health Specialty Solutions. Based on surveys with more than 85 U.S. rheumatologists, Rheumatology Insights focuses on key trends
August 27, 2021 by Chain Drug Review
Cardinal Health, RE ELiT
Leading Headlines, Pharmacy
DUBLIN, Ohio – Cardinal Health and IRE ELiT (the radiopharmaceutical subsidiary of IRE Group) are working to expand patient access to novel radiopharmaceuticals for Positron Emission Tomography (PET) imaging as demand in the United States (U.S.) continues to grow. Cardinal Health is the preferred U.S. distributor of the IRE ELiT 100 mCi Germanium-68/Gallium-68 radionuclide generator